Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens

DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA 94304, USA.
Journal of Experimental Medicine (Impact Factor: 12.52). 10/2001; 194(6). DOI: 10.1084/jem.194.6.863
Source: PubMed Central


Toll-like receptors (TLRs) are ancient microbial pattern recognition receptors highly conserved from Drosophila to humans. To investigate if subsets of human dendritic cell precursors (pre-DC), including monocytes (pre-DC1), plasmacytoid DC precursors (pre-DC2), and CD11c+ immature DCs (imDCs) are developed to recognize different microbes or microbial antigens, we studied their TLR expression and responses to microbial antigens. We demonstrate that whereas monocytes preferentially express TLR 1, 2, 4, 5, and 8, plasmacytoid pre-DC strongly express TLR 7 and 9. In accordance with these TLR expression profiles, monocytes respond to the known microbial ligands for TLR2 (peptidoglycan [PGN], lipoteichoic acid) and TLR4 (lipopolysaccharide), by producing tumor necrosis factor (TNF)-α and interleukin (IL)-6. In contrast, plasmacytoid pre-DCs only respond to the microbial TLR9-ligand, CpG-ODNs (oligodeoxynucleotides [ODNs] containing unmethylated CpG motifs), by producing IFN-α. CD11c+ imDCs preferentially express TLR 1, 2, and 3 and respond to TLR 2-ligand PGN by producing large amounts of TNF-α, and to viral double-stranded RNA-like molecule poly I:C, by producing IFN-α and IL-12. The expression of distinct sets of TLRs and the corresponding difference in reactivity to microbial molecules among subsets of pre-DCs and imDCs support the concept that they have developed through distinct evolutionary pathways to recognize different microbial antigens.

Download full-text


Available from: J. Fernando Bazan
  • Source
    • "Upregulated genes were also members of the B7 family, including B7.1 (CD80) and B7.2 (CD86), which specifically bind to their cognate ligand on T-cells and provide the second signal for T-cell activation and the enhancement of DC function, and CD40, a costimulatory protein that is required for DC activation by binding to CD40L on T H cells (Fig 3B). Results also showed the upregulation of several surface receptors (Fig 3C), including: 1) members of the Toll-like Receptor (TLR) family, such as TLR1, TLR2 and TLR7, which enhance antigen capture and cross presentation by DCs[18]; 2) FCγR1, which is involved in phagocytosis, antigen processing and cross-presentation via MHC class I molecules and cytokine signalling in adaptive immune responses and in ADCC[19]; and 3) the scavenger receptor CD91/LRP1 (Low-density Receptor-related Protein 1), recently shown to enhance antigen uptake within dendritic cells[20](Fig 3C). This is consistent with the notion that DCs use specialized immunoreceptors to efficiently internalize antigens before migrating to T cell-rich lymphoid structures. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Dendritic cells play a key role as initiators of T-cell responses, and even if tumour antigen-loaded dendritic cells can induce anti-tumour responses, their efficacy has been questioned, suggesting a need to enhance immunization strategies.
    Full-text · Article · Jan 2016 · PLoS ONE
  • Source
    • "pDCs display a plasma cell morphology and, under steady-state conditions, carry low levels of MHC-I and -II and costimulatory molecules[24]. Peculiarly, pDCs strongly express the pattern recognition receptors TLR7 and TLR9 and are thus capable of recognizing ssRNA and unmethylated CpG-containing DNA ligands, respectively[25]. Importantly, pDCs regulate cell trafficking through the production of CXCL10/IP-10 and other chemokines[26,27], provide help to NK cells[28], and also alter Th1/Th2 responses[29]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The interplay between IFN-λs and dendritic cells is becoming increasingly relevant, particularly in light of their key role in inducing the antiviral state, including in hepatitis C virus infection. In this work, we have analyzed extensively how human plasmacytoid dendritic cells respond to IFN-λ3. We report that plasmacytoid dendritic cells incubated with IFN-λ3 prolong their survival; alter their expression pattern of surface HLA-DRα, CD123, CD86, and CD303; and time dependently produce IFN-α, CXCL10/IFN-γ-induced protein 10, and even modest quantities of TNF-α. Nevertheless, endogenously produced TNF-α, but not IFN-α, was found to be essential for driving the expression of CXCL10/IFN-γ-induced protein 10 in IFN-λ3-treated plasmacytoid dendritic cells, as revealed by neutralizing experiments by use of adalimumab, etanercept, and infliximab. We also observed that based on the kinetics and levels of IFN-α and CXCL10/IFN-γ-induced protein 10 produced by their IFN-λ3-treated plasmacytoid dendritic cells, healthy donors could be categorized into 2 and 3 groups, respectively. In particular, we identified a group of donors whose plasmacytoid dendritic cells produced modest quantities of CXCL10/IFN-γ-induced protein 10; another one whose plasmacytoid dendritic cells produced elevated CXCL10/IFN-γ-induced protein 10 levels, already after 18 h, declining thereafter; and a 3rd group characterized by plasmacytoid dendritic cells releasing very high CXCL10/IFN-γ-induced protein 10 levels after 42 h only. Finally, we report that in plasmacytoid dendritic cells, equivalent concentrations of IFN-λ3 and IFN-λ1 promote survival, antigen modulation, and cytokine production in a comparable manner and without acting additively/synergistically. Altogether, data not only extend the knowledge on the biologic effects that IFN-λs exert on plasmacytoid dendritic cells but also add novel light to the networking between IFN-λs and plasmacytoid dendritic cells in fighting viral diseases.
    Full-text · Article · Sep 2015 · Journal of leukocyte biology
  • Source
    • "Although various TLRs, such as TLR3, TLR4, TLR5, TLR7 and TLR8 induce immune activation, others, e.g., TLR2 can silence immune responses through tolerance induction of DCs. The TLR2 activation induces IL-10 production, inhibits TLR7/TLR9 signaling and prevents interferon (IFN-α and -β) production (Kadowaki et al., 2001). Induction of immunological tolerance, specific for transplant or self-antigens while maintaining reactivity to other antigens, is an important goal in transplantation medicine and autoimmunity (Hilkens et al., 2010). "
    [Show abstract] [Hide abstract]
    ABSTRACT: immunosuppressive agents in the treatment of many autoimmune and allergic diseases. Aim: This study investigated the effect of the steroid dexamethasone (DEX) on maturation and differentiation of DCs derived from monocytes. In addition, an in vivo experiment was conducted to investigate whether treatment of mice with DEX has immunomodulatory effect on murine splenic DCs. Methods: In vitro experiment: Immature DCs were generated by incubating peripheral blood monocytes with cytokine cocktail (GM-CSF+IL-4) for 9 days. Phenotypic analysis of the DCs’ specific cell marker CD83 was performed by flow cytometry. In vivo experiment: Mice were randomly divided into 5 groups according to the dose of i.p., injection of DEX and duration of treatment. The murine splenic DCs were isolated and phenotyped for CD83 and CD11c by flow cytometry. Results: Addition of 1 μM DEX to the culture on day 7 or 8 resulted in a significant increase in the CD83 expression. The in vivo experiment showed that i.p. injection of DEX significantly increased the expression of CD83 on splenic DCs. Mice groups treated with a single dose of 20 mg kgG1 DEX showed a significant decrease of percentage of CD11c+CD83+ splenic DCs. Conclusion: DEX induced the DCs to be more tolerogenic both in vitro and in vivo. It could be suggested that DEX can trigger immunosuppressive effect via modulating the expression of the cell surface markers of DCs. Key words: Dendritic cells, dexamethasone, CD83, CD11c, murine splenic cells
    Full-text · Article · Jun 2015
Show more